National Survey on Gastroesophageal Reflux Disease (GERD) Patients (LINEA)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00695838
First received: June 10, 2008
Last updated: August 4, 2009
Last verified: August 2009
  Purpose

The purpose of this observational study is to assess the impact of abdominal fat on severity and frequency of GERD symptoms .


Condition
GERD

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the Impact of Abdominal Fat on GERD Severity and GERD Frequency in General Practice

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Waist circumference [ Time Frame: Once ]

Secondary Outcome Measures:
  • Frequency of GERD symptoms [ Time Frame: Once ]
  • GERD impact scale [ Time Frame: Once ]

Enrollment: 5084
Study Start Date: January 2008
Study Completion Date: December 2008

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

First three consecutive patients with GERD symptoms seen by GP

Criteria

Inclusion Criteria:

  • Male or female > or = 18 years old
  • Patient with symptomatic GERD
  • Without PPI or H2 antagonist treatment during the 3 previous months
  • Agree to take part in this study

Exclusion Criteria:

  • Pregnant women
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00695838

  Show 1638 Study Locations
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Alain Castaigne, Medical Director AstraZeneca
  More Information

No publications provided

Responsible Party: Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00695838     History of Changes
Other Study ID Numbers: NIS-GFR-DUM-2007/3
Study First Received: June 10, 2008
Last Updated: August 4, 2009
Health Authority: France: French Data Protection Authority

Keywords provided by AstraZeneca:
GERD symptoms- Waist circumference
Patients with symptomatic GERD

Additional relevant MeSH terms:
Gastroesophageal Reflux
Esophageal Motility Disorders
Deglutition Disorders
Esophageal Diseases
Gastrointestinal Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on April 17, 2014